HIV vaccine vCP1452

Drug Profile

HIV vaccine vCP1452

Alternative Names: ALVAC-HIV vCP1452; vCP1452

Latest Information Update: 20 Sep 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator sanofi pasteur
  • Class AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV-1 infections

Most Recent Events

  • 02 Aug 2007 Discontinued - Phase-I/II for HIV-1 infections in USA (IM)
  • 02 Aug 2007 Discontinued - Phase-II for HIV-1 infections in Brazil (IM)
  • 02 Aug 2007 Discontinued - Phase-II for HIV-1 infections in European Union (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top